Jefferies Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,000
Closed -$1.39M 1711
2022
Q2
$1.39M Sell
15,000
-58,700
-80% -$5.73M 0.01% 708
2022
Q1
$7.46M Buy
73,700
+31,200
+73% +$3.28M 0.05% 306
2021
Q4
$4.38M Sell
42,500
-57,800
-58% -$5.34M 0.03% 503
2021
Q3
$8.51M Buy
+100,300
New +$8.4M 0.06% 304
2021
Q1
Sell
-385,000
Closed -$26.3M 1692
2020
Q4
$26.3M Buy
385,000
+62,300
+19% +$4.05M 0.21% 71
2020
Q3
$18.8M Buy
322,700
+85,000
+36% +$5.29M 0.21% 64
2020
Q2
$15.4K Sell
237,700
-149,500
-39% -$9.41M 0.18% 77
2020
Q1
$23M Sell
387,200
-628,700
-62% -$42M 0.25% 56
2019
Q4
$75.5M Sell
1,015,900
-150,600
-13% -$10.6M 0.58% 19
2019
Q3
$73.6M Buy
1,166,500
+137,400
+13% +$8.14M 0.57% 11
2019
Q2
$56.1M Sell
1,029,100
-110,800
-10% -$5.97M 0.41% 23
2019
Q1
$61.5M Buy
1,139,900
+242,400
+27% +$15M 0.51% 21
2018
Q4
$58.8M Sell
897,500
-97,400
-10% -$7.27M 0.48% 22
2018
Q3
$78.3M Buy
994,900
+674,300
+210% +$48.2M 0.51% 20
2018
Q2
$20.6M Buy
320,600
+60,800
+23% +$4.01M 0.12% 110
2018
Q1
$16.2M Buy
259,800
+106,700
+70% +$7.66M 0.09% 152
2017
Q4
$11.1M Sell
153,100
-7,100
-4% -$516K 0.05% 282
2017
Q3
$13M Buy
160,200
+145,000
+954% +$11.5M 0.09% 208
2017
Q2
$1.22M Sell
15,200
-149,300
-91% -$11.8M 0.01% 1197
2017
Q1
$12.9M Sell
164,500
-124,200
-43% -$9.92M 0.1% 195
2016
Q4
$22.8M Buy
288,700
+146,300
+103% +$11.8M 0.13% 139
2016
Q3
$12.7M Sell
142,400
-30,600
-18% -$2.89M 0.07% 242
2016
Q2
$16.6M Buy
173,000
+89,900
+108% +$8.96M 0.08% 163
2016
Q1
$8.62M Buy
83,100
+28,800
+53% +$2.8M 0.05% 295
2015
Q4
$5.31M Buy
54,300
+23,600
+77% +$2.31M 0.03% 451
2015
Q3
$2.96M Buy
30,700
+15,200
+98% +$1.6M 0.02% 713
2015
Q2
$1.63M Sell
15,500
-94,700
-86% -$9.68M 0.01% 1022
2015
Q1
$11.4M Buy
+110,200
New +$11.2M 0.06% 214
2013
Q3
Sell
-18,800
Closed -$1.07M 1969
2013
Q2
$1.07M Buy
+18,800
New +$1.09M 0.01% 741

Other funds holding CVS

Jefferies Group's CVS Position: Q3 2022 in Review

Jefferies Group reduced its CVS Health (CVS) stake by 58% in Q3 2022, selling an estimated $421K and leaving 3,019 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Jefferies Group first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $17.8M in Q3 2016. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Jefferies Group held 3,019 shares of CVS Health worth $288K as of Q3 2022.
  • Jefferies Group sold 4,250 CVS Health shares in Q3 2022, an estimated $421K.
  • CVS Health made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1245 holding.
  • Jefferies Group first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
  • Jefferies Group's CVS Health position peaked at $17.8M in Q3 2016.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.